Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in HALOZYME THERAPEUTICS INC
BNP PARIBAS FINANCIAL MARKETS holds 338,291 shares of HALO (HALOZYME THERAPEUTICS INC), worth $21.9M as of 2026-Q1. The position was decreased (-46.6% shares). HALO represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$21.9M
Current Shares
338,291
Total Value Change
+$15.1M
Total Shares Change
+209,145
Other major holders of HALO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 338,291 |
-46.6% |
| $21.9M |
| 0.0% |
| $69.40 |
0 |
| 2025-Q4 | Decreased | 633,529 | -18.5% | $42.6M | 0.0% | $67.70 | 0 |
| 2025-Q3 | Increased | 776,986 | +189.4% | $57M | 0.0% | $73.29 | 47 |
| 2025-Q2 | Decreased | 268,431 | -39.4% | $14M | 0.0% | $52.21 | 0 |
| 2025-Q1 | Increased | 442,757 | +529.4% | $28.3M | 0.0% | $63.84 | 46 |
| 2024-Q4 | Increased | 70,344 | +69.5% | $3.4M | 0.0% | $47.99 | 39 |
| 2024-Q3 | Decreased | 41,495 | -67.9% | $2.4M | 0.0% | $56.97 | 0 |
| 2024-Q2 | Decreased | 129,146 | -56.5% | $6.8M | 0.0% | $52.36 | 0 |